Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Plus, some people experience digestive changes that can affect absorption
For patients who have struggled to sustain a healthy weight and need hormonal appetite support to do so, semaglutide provides a physician-supervised framework for long-term maintenance
Clinical trials for Mounjaro excluded patients with prior bariatric procedures, so direct research on this combination is limited
The absence of RCT data does not necessarily mean the product is ineffective Korean-origin products have historically reached European markets ahead of their Western peer-reviewed publication pipeline but practitioners should be explicit with patients that the evidence base is practitioner-reported rather than trial-validated
[1] [3] It belongs to a class of medicines called glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for type 2 diabetes management but now used for chronic weight management following NICE guidance and MHRA approval
Vesta prescribes compounded semaglutide (the same active ingredient in Ozempic and Wegovy) and compounded tirzepatide (the same active ingredient in Mounjaro and Zepbound)
US$ 26.95
US$ 27.65
US$ 21.69
